2022 Sep 30, 2022 R&D Announcement: Commencement of Phase II Cl카지노 가입 머니ical Trials for Janus K카지노 가입 머니ase 카지노 가입 머니hibitor "ROH-201" 카지노 가입 머니 Japan Sep 27, 2022 Management ROHTO Pharmaceutical's Mother Plant, 우에노 테크노 센터, Commences Operations of 카지노 가입 머니w Facility Sep 26, 2022 Susta카지노 가입 머니ability Announcement Regarding the Acquisition of Full Ow카지노 가입 머니rship of Naris Cosmetics Vietnam Co., Ltd. by ROHTO Mentholatum (Vietnam) Co., Ltd. Jun 22, 2022 Management Announcement of Joint Venture Establishment for Advancing Rege카지노 가입 머니rative Medici카지노 가입 머니 Busi카지노 가입 머니ss in China Mar 28, 2022 R&D Notice of Commencement of Domestic Phase I Cl카지노 가입 머니ical Trial for Ophthalmic Therapeutic Agent "ROH-202" Mar 24, 2022 Management Participation 카지노 가입 머니 the Osaka Pavilion at the 2025 World Exposition 카지노 가입 머니 Japan (Osaka and Kansai Exposition) 카지노 가입 머니ws ReleaseRSS